SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
-------------
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Optomedic Medical Technologies Ltd.
(Exact Name of Registrant as Specified in Its Charter)
Israel Not Applicable
(State of Incorporation or Organization) (I.R.S. Employer
Identification no.)
Yoni Netanyahu 3-B
Or-Yehuda 60376, Israel (Zip Code)
(Address of Principal Executive Offices)
If this form relates to the If this form relates to the
registration of a class of registration of a class of
securities pursuant to Rule securities pursuant to Section
12(b) of the Exchange Act and 12(g) of the Exchange Act and
is effective pursuant to General is effective pursuant to
Instruction A.(c), please check General Instruction A.(d),
the following box. [ ] please check the following
box. [X]
Securities Act registration statement file number to which this
form relates: 333-8632
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Name of Each Exchange on Which
to be so Registered Each Class is to be Registered
Ordinary Shares, nominal Nasdaq SmallCap Market
value NIS 0.01 per share
Redeemable Ordinary Share Nasdaq SmallCap Market
Purchase Warrants
Securities to be registered pursuant to Section 12(g) of the Act:
Item 1. Description of Registrant's Securities to be
Registered.
See "Description of Securities" in the Company's
Registration Statement on Form F-1, as amended,
(Registration No. 333-8632)(the "Form F-1"), filed with the
Securities and Exchange Commission, which information is
hereby incorporated herein by reference.
Item 2. Exhibits.
A. Articles of Association of the Company, as amended.
Filed with the Securities and Exchange Commission as
Exhibit 3.2 to the Form F-1, and incorporated herein by
reference.
B. Form of Warrant Agent Agreement. Filed with the
Securities and Exchange Commission as Exhibit 4.4 to
the Form F-1, and incorporated herein by reference.
C. Form of Convertible Debenture. Filed with the
Securities and Exchange Commission as Exhibit 4.5 to
the Form F-1, and incorporated herein by reference.
SIGNATURE
Pursuant to the requirements of Section 12 of the
Securities Exchange Act of 1934, the registrant has duly caused
this registration statement to be signed on its behalf by the
undersigned, thereto duly authorized.
Optomedic Medical Technologies Ltd.
(Registrant)
Date: May 18, 1998 By: /s/ Alex Harel
Name: Alex Harel
Title: President and Chief
Executive Officer
